-
The Global Antimicrobial Coatings Market is Projected to Exceed $10.1 Billion by 2032
The global antimicrobial coatings market is forecast to surpass $10.1 billion by 2032, primarily driven by the increasing focus on hygiene standards a...
2024-07-22 15:24 -
Johnson & Johnson Reports Strong H1 2024 Results, Revenue Reaches $43.8 Billion
Johnson & Johnson, the world's leading healthcare company, recently released its financial results for the first half of 2024, demonstrating its solid...
2024-07-19 17:46 -
Boehringer Ingelheim Reports 7.4% Sales Growth to €12.9 Billion in the First Half of 2024
Boehringer Ingelheim delivered a solid business performance in the first half of 2024, achieving a significant increase in net sales, up 7.4% year-on-...
2024-07-19 17:45 -
Radioliant Technology Licenses Radiopharmaceutical to South Korea for $571.5 Million
China's leading radiation therapy company has signed a global licensing agreement worth $571.5 million with South Korean biotech giant SKBiopharmaceut...
2024-07-19 17:43 -
Soaring US Biotech Drugs and the Sluggish Domestic Biotech Market
The power of the market is like an invisible giant hand, quietly affecting the rise and fall of every industry.
2024-07-19 17:42 -
NVIDIA Extends AI Footprint in Pharmaceuticals, Forges Partnership with Pfizer
Global technology giant Nvidia's layout in the field of AI pharmaceuticals has once again attracted attention, this time, it has chosen to join forces...
2024-07-19 17:41 -
Biomedical Highlights: CAR-T Therapy Sales Soar, Philips Recalls Respiratory Devices
The global pharmaceutical industry has recently witnessed a number of compelling developments that demonstrate not only the innovation of the industry...
2024-07-19 17:38 -
CRC Group Continues Expansion with $1.8 Billion Acquisition
China Resources Boyalife announced on July 19, 2024 that it will fully acquire the entire equity of Green Cross Hong Kong Holdings Limited held by GC ...
2024-07-19 17:36 -
Eisai and Sato Pharmaceutical Collaborate on Development of Novel Antifungal Drug Fosravuconazole in...
Eisai and Japan's Sato Pharmaceutical have announced a major collaboration, entering into a licensing agreement for the development and marketing righ...
2024-07-18 17:37 -
AusperBio Completes $37 Million Series A Financing
Recently, AusperBio announced that it has successfully completed A Series A funding round of up to $37 million.
2024-07-18 17:36
Hot News
- 关于进一步规范化学品信息发布、... Jan 27, 2026
- BASF’s 2025 Report Card—“Th... Jan 27, 2026
- Invista Reshuffles Global Nylo... Jan 28, 2026
- 5%–10% Is Just the Surface: B... Jan 15, 2026
- “Europe’s Chemical Industry ... Feb 02, 2026
Related Products
Related Producers
